Armata Pharmaceuticals, Inc.
General ticker "ARMP" information:
- Sector: Health Care
- Industry: Biotechnology
- Capitalization: $215.3M (TTM average)
Armata Pharmaceuticals, Inc. does not follow the US Stock Market performance with the rate: -0.1%.
Estimated limits based on current volatility of 4.2%: low 5.21$, high 5.67$
Factors to consider:
- Total employees count: 66 (-12.0%) as of 2023
- Company does not operate outside US (retrieved using AI)
- Top business risk factors: Going concern doubt, Need for additional capital, Clinical trial failure, Regulatory and compliance, Manufacturing scale up
- Price in estimated range
- Earnings for 6 months up through Q2 are below our estimates
Stock Forecast*
* forecast is subjective and experimental, should not be used for any investment decisions
Long term estimates were made for the period from 2025-12-31 to 2027-12-31
- 2025-12-31 to 2026-12-31 estimated range: [3.79$, 11.11$]
- 2026-12-31 to 2027-12-31 estimated range: [2.87$, 8.45$]
Financial Metrics affecting the ARMP estimates:
- Negative: with PPE of -1.3 at the end of fiscal year the price was high
- Negative: negative Operating income
- Negative: Operating cash flow per share per price, % of -11.18 <= 0.28
- Negative: negative Net income
- Negative: negative Industry operating income (median)
- Positive: Investing cash flow per share per price, % of -0.24 > -0.64
- Negative: Shareholder equity ratio, % of -284.33 <= 18.97
- Positive: Inventory ratio change, % of 0 <= 0
Short-term ARMP quotes
Long-term ARMP plot with estimates
Financial data
| YTD | 2023-12-31 | 2024-12-31 | 2025-12-31 |
|---|---|---|---|
| Operating Revenue | $4.53MM | $5.17MM | $4.90MM |
| Operating Expenses | $45.42MM | $47.61MM | $41.54MM |
| Operating Income | $-40.89MM | $-42.44MM | $-36.63MM |
| Non-Operating Income | $-28.16MM | $23.52MM | $-137.16MM |
| R&D Expense | $33.77MM | $34.43MM | $23.72MM |
| Income(Loss) | $-69.05MM | $-18.92MM | $-173.80MM |
| Net Income(Loss)* | $-69.05MM | $-18.92MM | $-173.80MM |
| Stockholders Equity | $-32.06MM | $-48.02MM | $-218.60MM |
| Assets | $98.36MM | $86.44MM | $76.88MM |
| Operating Cash Flow | $-47.42MM | $-37.55MM | $-25.76MM |
| Capital expenditure | $8.14MM | $1.88MM | $0.54MM |
| Investing Cash Flow | $-8.13MM | $-1.88MM | $-0.54MM |
| Financing Cash Flow | $53.99MM | $34.96MM | $25.61MM |
| Earnings Per Share** | $-1.91 | $-0.52 | $-4.80 |
* Profit(Loss) attributable to entity.
** EPS are Split Adjusted, recent splits may be reflected with a delay.